DiaMedica Therapeutics
DMAC
DMAC
57 hedge funds and large institutions have $33.6M invested in DiaMedica Therapeutics in 2025 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 18 increasing their positions, 5 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
57
Holders Change
–
Holders Change %
0%
% of All Funds
0.76%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
21
Increased
18
Reduced
5
Closed
21
Calls
$8K
Puts
$1K
Net Calls
+$7K
Net Calls Change
-$41K
Top Buyers
1 |
BlackRock
New York
|
$4.65M |
2 |
Geode Capital Management
Boston,
Massachusetts
|
$2.46M |
3 |
Vanguard Group
Malvern,
Pennsylvania
|
$5.99M |
4 |
State Street
Boston,
Massachusetts
|
$983K |
5 |
Northern Trust
Chicago,
Illinois
|
$1.27M |